Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional 5-fluorouracil versus cryotherapy for palmoplantar warts
PACTR202505517735790Completed
- Sponsor
- Osama Elshabory
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fluorouracil in Palmoplantar wart (2 arms), sponsored by Osama Elshabory. Primary endpoint: Clinical efficacy. Started Nov 2023; status: completed.
02
Drugs
fluorouracil
03
Conditions
Palmoplantar wart
Beyond the preview
Go deeper on PACTR202505517735790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202505517735790.